DAVOS, Switzerland / Jan 16, 2024 / Business Wire / The world faces an emergency in women’s health even as the COVID-19 pandemic wanes, according to one of the largest annual updates on women’s well-being — the Hologic Global Women’s Health Index.
Women’s health innovation company Hologic, Inc. (Nasdaq: HOLX) partners with Gallup to create the Index, which in its third year shows that billions of women are not getting tested for potentially life-threatening conditions. The Index also shows that more women are sad, angry and worried now than at the height of the pandemic. Many young women don’t feel safe walking alone in their communities at night, and nearly 1 billion women spend a lot of their day in physical pain.
This year’s Index will be released today at the World Economic Forum in Davos, Switzerland. The launch event was convened by Goals House, a community that comes together at significant global moments throughout the year to drive progress toward the United Nations (UN) Sustainable Development Goals (SDGs).
The Index fills a critical gap in knowledge about the health, safety and well-being of women worldwide. Based on interviews with more than 147,000 women and men in 143 countries and territories, it represents the voices of 97% of the world’s women and girls aged 15 and older.
“The new Index findings make it exceedingly evident that, as countries emerge from the COVID-19 pandemic, women’s health remains in a state of emergency,” said Stephen P. MacMillan, Chairman, President and CEO of Hologic. “It’s time for world leaders to take a bolder stand for women and girls. Investing in women’s health not only benefits individual women, but also their families, communities and economies.”
Key findings from this year’s Index:
Based on survey responses, the Index assigns a women’s health score to each country or territory. Taiwan led the world for the third consecutive year, scoring 72 out of a possible 100. Other top scores went to Kuwait (68), Austria (67) and Germany (67). The lowest scores went to the Democratic Republic of Congo (36), Sierra Leone (34) and Afghanistan (26).
The United States fell seven places from its ranking in the second year of the survey to number 30, on par with Kazakhstan. The United Kingdom and France both scored 60, a few points above the global average.
“The Index serves as a wake-up call that improving women’s health needs to be a top priority. If we follow the roadmap set out in this Index, we can meaningfully improve the health and well-being of women for generations to come,” said MacMillan.
This year’s Index report includes country spotlights, including case studies on what is working well. South Korea is a consistent leader in cancer testing, and after recent prioritization, Costa Rica is among the top countries for blood pressure testing.
To see the full Index and related resources, visit WomensHealthIndex.com.
About Hologic, Inc.
Hologic, Inc. is a global medical technology innovator focused on improving the health and well-being of women, their families and communities through early detection and treatment. Its advancements include invention of the world’s first commercial 3D mammography system to find breast cancer earlier; leadership in testing for cervical cancer, sexually transmitted infections and respiratory illnesses; and minimally invasive surgical technologies for uterine fibroids and abnormal uterine bleeding.
About Gallup
Gallup delivers analytics and advice to help leaders and organizations solve their most pressing problems. Combining more than 80 years of experience with its global reach, Gallup knows more about the attitudes and behaviors of employees, customers, students and citizens than any other organization in the world.
Last Trade: | US$71.65 |
Daily Change: | 0.89 1.26 |
Daily Volume: | 7,640,910 |
Market Cap: | US$16.260B |
December 18, 2024 December 09, 2024 December 02, 2024 November 04, 2024 |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORECompass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB